Industry Research Reports

Home > Reports > Pharma & Healthcare > Antidepressants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Antidepressants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 125 Pages

Report ld: 2343317

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Antidepressants was estimated to be worth US$ 14360 million in 2023 and is forecast to a readjusted size of US$ 18090 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Antidepressants Market Size

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidepressants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antidepressants by region & country, by Type, and by Application.

The Antidepressants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidepressants.

Market Segmentation

Report Metric
Details
Report Title
Antidepressants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 18090 million
CAGR(2024-2030)
3.3%
Market Size Available for Years
2019-2030
Global Antidepressants Companies Covered
H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson, Merck, Sanofi
Global Antidepressants Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidepressants Market, Segment by Type
Tricyclic Antidepressants

Selective Serotonin Reuptake Inhibitors

Selective Norepinephrine Reuptake Inhibitors

Monoamine Oxidase Inhibitors

Benzodiazepines

Antipsychotics

Novel Agents
Global Antidepressants Market, Segment by Application
Hospitals

Clinics

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antidepressants in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Antidepressants Product Introduction
    1.2 Global Antidepressants Market Size Forecast
        1.2.1 Global Antidepressants Sales Value (2019-2030)
        1.2.2 Global Antidepressants Sales Volume (2019-2030)
        1.2.3 Global Antidepressants Sales Price (2019-2030)
    1.3 Antidepressants Market Trends & Drivers
        1.3.1 Antidepressants Industry Trends
        1.3.2 Antidepressants Market Drivers & Opportunity
        1.3.3 Antidepressants Market Challenges
        1.3.4 Antidepressants Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Antidepressants Players Revenue Ranking (2023)
    2.2 Global Antidepressants Revenue by Company (2019-2024)
    2.3 Global Antidepressants Players Sales Volume Ranking (2023)
    2.4 Global Antidepressants Sales Volume by Company Players (2019-2024)
    2.5 Global Antidepressants Average Price by Company (2019-2024)
    2.6 Key Manufacturers Antidepressants Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Antidepressants Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Antidepressants
    2.9 Antidepressants Market Competitive Analysis
        2.9.1 Antidepressants Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Antidepressants Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressants as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Tricyclic Antidepressants
        3.1.2 Selective Serotonin Reuptake Inhibitors
        3.1.3 Selective Norepinephrine Reuptake Inhibitors
        3.1.4 Monoamine Oxidase Inhibitors
        3.1.5 Benzodiazepines
        3.1.6 Antipsychotics
        3.1.7 Novel Agents
    3.2 Global Antidepressants Sales Value by Type
        3.2.1 Global Antidepressants Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Antidepressants Sales Value, by Type (2019-2030)
        3.2.3 Global Antidepressants Sales Value, by Type (%) (2019-2030)
    3.3 Global Antidepressants Sales Volume by Type
        3.3.1 Global Antidepressants Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Antidepressants Sales Volume, by Type (2019-2030)
        3.3.3 Global Antidepressants Sales Volume, by Type (%) (2019-2030)
    3.4 Global Antidepressants Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Other
    4.2 Global Antidepressants Sales Value by Application
        4.2.1 Global Antidepressants Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Antidepressants Sales Value, by Application (2019-2030)
        4.2.3 Global Antidepressants Sales Value, by Application (%) (2019-2030)
    4.3 Global Antidepressants Sales Volume by Application
        4.3.1 Global Antidepressants Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Antidepressants Sales Volume, by Application (2019-2030)
        4.3.3 Global Antidepressants Sales Volume, by Application (%) (2019-2030)
    4.4 Global Antidepressants Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Antidepressants Sales Value by Region
        5.1.1 Global Antidepressants Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Antidepressants Sales Value by Region (2019-2024)
        5.1.3 Global Antidepressants Sales Value by Region (2025-2030)
        5.1.4 Global Antidepressants Sales Value by Region (%), (2019-2030)
    5.2 Global Antidepressants Sales Volume by Region
        5.2.1 Global Antidepressants Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Antidepressants Sales Volume by Region (2019-2024)
        5.2.3 Global Antidepressants Sales Volume by Region (2025-2030)
        5.2.4 Global Antidepressants Sales Volume by Region (%), (2019-2030)
    5.3 Global Antidepressants Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Antidepressants Sales Value, 2019-2030
        5.4.2 North America Antidepressants Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Antidepressants Sales Value, 2019-2030
        5.5.2 Europe Antidepressants Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Antidepressants Sales Value, 2019-2030
        5.6.2 Asia Pacific Antidepressants Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Antidepressants Sales Value, 2019-2030
        5.7.2 South America Antidepressants Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Antidepressants Sales Value, 2019-2030
        5.8.2 Middle East & Africa Antidepressants Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Antidepressants Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Antidepressants Sales Value
        6.2.1 Key Countries/Regions Antidepressants Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Antidepressants Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Antidepressants Sales Value, 2019-2030
        6.3.2 United States Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Antidepressants Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Antidepressants Sales Value, 2019-2030
        6.4.2 Europe Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Antidepressants Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Antidepressants Sales Value, 2019-2030
        6.5.2 China Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Antidepressants Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Antidepressants Sales Value, 2019-2030
        6.6.2 Japan Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Antidepressants Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Antidepressants Sales Value, 2019-2030
        6.7.2 South Korea Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Antidepressants Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Antidepressants Sales Value, 2019-2030
        6.8.2 Southeast Asia Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Antidepressants Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Antidepressants Sales Value, 2019-2030
        6.9.2 India Antidepressants Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Antidepressants Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 H Lundbeck
        7.1.1 H Lundbeck Company Information
        7.1.2 H Lundbeck Introduction and Business Overview
        7.1.3 H Lundbeck Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 H Lundbeck Antidepressants Product Offerings
        7.1.5 H Lundbeck Recent Development
    7.2 Astrazeneca
        7.2.1 Astrazeneca Company Information
        7.2.2 Astrazeneca Introduction and Business Overview
        7.2.3 Astrazeneca Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Astrazeneca Antidepressants Product Offerings
        7.2.5 Astrazeneca Recent Development
    7.3 Eli Lilly and Company
        7.3.1 Eli Lilly and Company Company Information
        7.3.2 Eli Lilly and Company Introduction and Business Overview
        7.3.3 Eli Lilly and Company Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Eli Lilly and Company Antidepressants Product Offerings
        7.3.5 Eli Lilly and Company Recent Development
    7.4 Sun Pharmaceuticals
        7.4.1 Sun Pharmaceuticals Company Information
        7.4.2 Sun Pharmaceuticals Introduction and Business Overview
        7.4.3 Sun Pharmaceuticals Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Sun Pharmaceuticals Antidepressants Product Offerings
        7.4.5 Sun Pharmaceuticals Recent Development
    7.5 Pfizer Inc.
        7.5.1 Pfizer Inc. Company Information
        7.5.2 Pfizer Inc. Introduction and Business Overview
        7.5.3 Pfizer Inc. Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Pfizer Inc. Antidepressants Product Offerings
        7.5.5 Pfizer Inc. Recent Development
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Company Information
        7.6.2 GlaxoSmithKline Introduction and Business Overview
        7.6.3 GlaxoSmithKline Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 GlaxoSmithKline Antidepressants Product Offerings
        7.6.5 GlaxoSmithKline Recent Development
    7.7 Bristol-Myers Squibb Company
        7.7.1 Bristol-Myers Squibb Company Company Information
        7.7.2 Bristol-Myers Squibb Company Introduction and Business Overview
        7.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Bristol-Myers Squibb Company Antidepressants Product Offerings
        7.7.5 Bristol-Myers Squibb Company Recent Development
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Company Information
        7.8.2 Johnson & Johnson Introduction and Business Overview
        7.8.3 Johnson & Johnson Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Johnson & Johnson Antidepressants Product Offerings
        7.8.5 Johnson & Johnson Recent Development
    7.9 Merck
        7.9.1 Merck Company Information
        7.9.2 Merck Introduction and Business Overview
        7.9.3 Merck Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Merck Antidepressants Product Offerings
        7.9.5 Merck Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Company Information
        7.10.2 Sanofi Introduction and Business Overview
        7.10.3 Sanofi Antidepressants Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Sanofi Antidepressants Product Offerings
        7.10.5 Sanofi Recent Development

 8 Industry Chain Analysis
    8.1 Antidepressants Industrial Chain
    8.2 Antidepressants Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Antidepressants Sales Model
        8.5.2 Sales Channel
        8.5.3 Antidepressants Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Antidepressants Market Trends
    Table 2. Antidepressants Market Drivers & Opportunity
    Table 3. Antidepressants Market Challenges
    Table 4. Antidepressants Market Restraints
    Table 5. Global Antidepressants Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antidepressants Revenue Market Share by Company (2019-2024)
    Table 7. Global Antidepressants Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Antidepressants Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Antidepressants Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Antidepressants Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Antidepressants Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Antidepressants
    Table 13. Global Antidepressants Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressants as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antidepressants Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Antidepressants Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Antidepressants Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Antidepressants Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Antidepressants Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Antidepressants Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Antidepressants Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Antidepressants Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Antidepressants Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Antidepressants Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Antidepressants Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Antidepressants Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Antidepressants Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Antidepressants Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Antidepressants Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Antidepressants Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Antidepressants Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Antidepressants Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Antidepressants Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Antidepressants Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Antidepressants Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Antidepressants Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Antidepressants Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Antidepressants Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Antidepressants Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Antidepressants Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Antidepressants Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Antidepressants Sales Value by Region (2019-2024) & (%)
    Table 44. Global Antidepressants Sales Value by Region (2025-2030) & (%)
    Table 45. Global Antidepressants Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Antidepressants Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Antidepressants Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Antidepressants Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Antidepressants Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Antidepressants Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Antidepressants Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Antidepressants Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Antidepressants Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Antidepressants Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Antidepressants Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Antidepressants Sales Volume, (2025-2030) & (K Units)
    Table 57. H Lundbeck Company Information
    Table 58. H Lundbeck Introduction and Business Overview
    Table 59. H Lundbeck Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. H Lundbeck Antidepressants Product Offerings
    Table 61. H Lundbeck Recent Development
    Table 62. Astrazeneca Company Information
    Table 63. Astrazeneca Introduction and Business Overview
    Table 64. Astrazeneca Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Astrazeneca Antidepressants Product Offerings
    Table 66. Astrazeneca Recent Development
    Table 67. Eli Lilly and Company Company Information
    Table 68. Eli Lilly and Company Introduction and Business Overview
    Table 69. Eli Lilly and Company Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Eli Lilly and Company Antidepressants Product Offerings
    Table 71. Eli Lilly and Company Recent Development
    Table 72. Sun Pharmaceuticals Company Information
    Table 73. Sun Pharmaceuticals Introduction and Business Overview
    Table 74. Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Sun Pharmaceuticals Antidepressants Product Offerings
    Table 76. Sun Pharmaceuticals Recent Development
    Table 77. Pfizer Inc. Company Information
    Table 78. Pfizer Inc. Introduction and Business Overview
    Table 79. Pfizer Inc. Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Pfizer Inc. Antidepressants Product Offerings
    Table 81. Pfizer Inc. Recent Development
    Table 82. GlaxoSmithKline Company Information
    Table 83. GlaxoSmithKline Introduction and Business Overview
    Table 84. GlaxoSmithKline Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. GlaxoSmithKline Antidepressants Product Offerings
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Bristol-Myers Squibb Company Company Information
    Table 88. Bristol-Myers Squibb Company Introduction and Business Overview
    Table 89. Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Bristol-Myers Squibb Company Antidepressants Product Offerings
    Table 91. Bristol-Myers Squibb Company Recent Development
    Table 92. Johnson & Johnson Company Information
    Table 93. Johnson & Johnson Introduction and Business Overview
    Table 94. Johnson & Johnson Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Johnson & Johnson Antidepressants Product Offerings
    Table 96. Johnson & Johnson Recent Development
    Table 97. Merck Company Information
    Table 98. Merck Introduction and Business Overview
    Table 99. Merck Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Merck Antidepressants Product Offerings
    Table 101. Merck Recent Development
    Table 102. Sanofi Company Information
    Table 103. Sanofi Introduction and Business Overview
    Table 104. Sanofi Antidepressants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Sanofi Antidepressants Product Offerings
    Table 106. Sanofi Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Antidepressants Downstream Customers
    Table 110. Antidepressants Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antidepressants Product Picture
    Figure 2. Global Antidepressants Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Antidepressants Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Antidepressants Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Antidepressants Report Years Considered
    Figure 7. Global Antidepressants Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Antidepressants Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidepressants Revenue in 2023
    Figure 10. Antidepressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tricyclic Antidepressants Picture
    Figure 12. Selective Serotonin Reuptake Inhibitors Picture
    Figure 13. Selective Norepinephrine Reuptake Inhibitors Picture
    Figure 14. Monoamine Oxidase Inhibitors Picture
    Figure 15. Benzodiazepines Picture
    Figure 16. Antipsychotics Picture
    Figure 17. Novel Agents Picture
    Figure 18. Global Antidepressants Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Antidepressants Sales Value Market Share by Type, 2023 & 2030
    Figure 20. Global Antidepressants Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 21. Global Antidepressants Sales Volume Market Share by Type, 2023 & 2030
    Figure 22. Global Antidepressants Price by Type (2019-2030) & (USD/Unit)
    Figure 23. Product Picture of Hospitals
    Figure 24. Product Picture of Clinics
    Figure 25. Product Picture of Other
    Figure 26. Global Antidepressants Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Antidepressants Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Antidepressants Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 29. Global Antidepressants Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Antidepressants Price by Application (2019-2030) & (USD/Unit)
    Figure 31. North America Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Antidepressants Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Antidepressants Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Antidepressants Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Antidepressants Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Antidepressants Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Antidepressants Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Antidepressants Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Antidepressants Sales Volume (%), (2019-2030)
    Figure 43. United States Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Antidepressants Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Antidepressants Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Antidepressants Sales Value by Application (%), 2023 VS 2030
    Figure 64. Antidepressants Industrial Chain
    Figure 65. Antidepressants Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Description

The global market for Antidepressants was estimated to be worth US$ 14360 million in 2023 and is forecast to a readjusted size of US$ 18090 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidepressants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antidepressants by region & country, by Type, and by Application.

The Antidepressants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidepressants.

Market Segmentation